Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Accumulated Expenses (2020 - 2025)

Bio Essence has reported Accumulated Expenses over the past 6 years, most recently at $2287.0 for Q1 2025.

  • For Q1 2025, Accumulated Expenses fell 3.05% year-over-year to $2287.0; the TTM value through Mar 2025 reached $2287.0, down 3.05%, while the annual FY2024 figure was $2306.0, 2.99% down from the prior year.
  • Accumulated Expenses for Q1 2025 was $2287.0 at Bio Essence, down from $2306.0 in the prior quarter.
  • Over five years, Accumulated Expenses peaked at $16805.0 in Q1 2023 and troughed at $2287.0 in Q1 2025.
  • A 5-year average of $8432.5 and a median of $6812.0 in 2021 define the central range for Accumulated Expenses.
  • Biggest five-year swings in Accumulated Expenses: soared 175.4% in 2021 and later crashed 86.01% in 2024.
  • Year by year, Accumulated Expenses stood at $13054.0 in 2021, then crashed by 48.25% to $6756.0 in 2022, then plummeted by 64.82% to $2377.0 in 2023, then decreased by 2.99% to $2306.0 in 2024, then decreased by 0.82% to $2287.0 in 2025.
  • Business Quant data shows Accumulated Expenses for BIOE at $2287.0 in Q1 2025, $2306.0 in Q4 2024, and $2324.0 in Q3 2024.